Full Year 2019 Oxford BioMedica PLC Earnings Call Transcript
Good day, ladies and gentlemen. Thank you for standing by. And welcome to the Oxford Biomedica preliminary results webcast and conference call. (Operator Instructions) I must also advise you the conference is being recorded today.
Now I would like to hand the conference over to Catherine Isted, Head of Corporate Development and Investor Relations. Please go ahead, madam.
Good afternoon or good morning. Welcome to Oxford Biomedica's results presentation for the full year ending the 31st of December 2019.
We're all living in unprecedented times due to COVID-19, and we want to thank you all for joining us today on what will be a slightly different results day briefing to normal. We hope that everyone is keeping safe and well, and we look forward to a time when we can meet you again in person.
On the call today is John Dawson, our CEO; and Stuart Paynter, our CFO. As a reminder, there will be an opportunity at the end of the call to field questions.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |